The Forum on Neuroscience and Nervous System Disorders hosted a public workshop on September 8, 2017 that brought together key experts from academia, government, the biotechnology and pharmaceutical ...

Multimodal therapy approaches (i.e., combinations of interventions aimed at different aspects of a disease) are emerging as potential ways to enhance clinical outcomes for patients with psychiatric ...

HOUSTON. Amgen, the largest biotechnology company in the world, is funding research focusing on disorders that destroy parts of the nervous system. These include Alzheimer's disease, Parkinson's ...

The enteric nervous system (ENS) is a sophisticated, autonomous network of neurons and glia embedded within the gastrointestinal tract, critical for regulating motility, secretion, and blood flow. The ...

A sudden sensation of numbness? The nagging headache that just won’t quit? That weird weakness in your leg? They’re all symptoms of neurological disorders — a family of conditions that affects more ...

The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of Roche's top-selling drug ocrelizumab (Ocrevus) for treating primary progressive multiple sclerosis (PPMS)—a ...

(Beyond Pesticides, July 29, 2025) Are neurological diseases increasing around the world? Yes and no, according to a report published by The Lancet in 2024 on the global burden of nervous system ...

This clinical-stage biotech focused on CNS disorders reported a notable insider sale, as disclosed in its latest SEC filing.

Neurological disorders affect the function of the nervous system. Common pediatric neurological disorders include ADHD, autism spectrum disorder, epilepsy, and cerebral palsy. Neurological disorders ...